Array Technologies, Inc. Reports Financial Results for the Second Quarter 2022 – Outperforms on revenue and adjusted EBITDA, delivers organic growth of 79% in Array Legacy Operation segment, and has
Go back to Array Technologies, Inc. Reports Financial Results for the Second Quarter 2022 – Outperforms on revenue and adjusted EBITDA, delivers organic growth of 79% in Array Legacy Operation segment, and has| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 8.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.54 | 52 Week High | $7.27 | |||
| Open | $8.54 | 52 Week Low | $2.39 | |||
| Day High | $8.54 | P/E | N/A | |||
| Day Low | $8.54 | EPS | $-0.61 | |||
| Volume | 34,306 | |||||
